Literature DB >> 9331002

Bioavailability of candesartan is unaffected by food in healthy volunteers administered candesartan cilexetil.

J G Riddell1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331002

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  8 in total

Review 1.  Clinical pharmacokinetics of candesartan.

Authors:  Christoph H Gleiter; Klaus E Mörike
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis.

Authors:  M Pfister; F Schaedeli; F J Frey; D E Uehlinger
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 3.  Candesartan cilexetil: an update of its use in essential hypertension.

Authors:  Stephanie E Easthope; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.

Authors:  Ezequiel Balmori Melian; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of losartan.

Authors:  Domenic A Sica; Todd W B Gehr; Siddhartha Ghosh
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 6.  Candesartan cilexetil. A review of its use in essential hypertension.

Authors:  K J McClellan; K L Goa
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

7.  Clinical pharmacology of the angiotensin receptor antagonists.

Authors:  D A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Jan-Feb       Impact factor: 3.738

Review 8.  Candesartan in heart failure.

Authors:  Toni L Ripley; Jennifer S Chonlahan; Robin E Germany
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.